Basking Ridge, NJ, United States of America

Goutam Muhuri

This inventor holds 1 USPTO granted patent and 2 published patent applications, plus 1 CIPO patent. Top assignee: Jubilant Generics Limited. Active years: 2018.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Goutam Muhuri. Retrieved from https://idiyas.com/inventor/goutam-muhuri

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 1 


Average Co-Inventor Count = 5.0

ph-index = 1


Company Filing History:


Years Active: 2018

Loading Chart...
Loading Chart...
1 patent (USPTO):Explore Patents

Title: Goutam Muhuri: Innovator in Pharmaceutical Composition

Introduction

Goutam Muhuri is a notable inventor based in Basking Ridge, NJ (US). He has made significant contributions to the field of pharmaceuticals, particularly in the formulation of compositions that enhance drug efficacy.

Latest Patents

Goutam holds a patent for a disintegrant-free composition of Cinacalcet. This invention relates to a pharmaceutical composition of Cinacalcet or a pharmaceutically acceptable salt thereof, which includes diluents, binders, and lubricants, while being substantially free of disintegrants. The patent also outlines the process for preparing such compositions.

Career Highlights

Goutam is currently associated with Jubilant Generics Limited, where he applies his expertise in pharmaceutical development. His work focuses on creating innovative solutions that improve drug formulations and patient outcomes.

Collaborations

Goutam collaborates with talented professionals in his field, including Ravikumar Nithiyanandam and Ganesh Vinayak Gat. These partnerships enhance the research and development efforts at Jubilant Generics Limited.

Conclusion

Goutam Muhuri's contributions to pharmaceutical compositions exemplify the importance of innovation in healthcare. His work continues to impact the industry positively, paving the way for advancements in drug formulation.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…